Novartis Pharmaceuticals Corporation
UnclaimedPharmaceutical Preparation ManufacturingEast Hanover, NJ
Founded
1996
Primary NAICS
325412
CAGE code
04520
Federal awards
$32.2M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $33,169,414 | 73 |
| 2026 | Department of Defense | $4,292,412 | 9 |
| 2026 | Department of Justice | $43,520 | 3 |
| 2026 | Department of Health and Human Services | -$2,539,496 | 1 |
| 2025 | Department of Veterans Affairs | $8,214,789 | 50 |
| 2025 | Department of Defense | $426,053 | 4 |
| 2024 | Department of Veterans Affairs | $0 | 30 |
| 2023 | Department of Veterans Affairs | $0 | 35 |
| 2023 | Department of Health and Human Services | -$18,841,773 | 3 |
| 2022 | Department of Health and Human Services | $7,393,435 | 1 |
| 2022 | Department of Veterans Affairs | $0 | 41 |